SMB·BIO

Enex pivots toward 'lifestyle solutions' with biotech investment

by
조 문술
Published : June 9, 2026 - 16:55:02
    • Copy Completed!

View Korean Original

Company acquires 6.67% stake in Dermatobio for 2 billion won ($1.29 million); plans to expand into cosmetics, medical device retail targeting single-person households and elderly

Enex CEO Park Jin-gyu (front row, left) and Dermatobio CEO Ahn Seong-gwan sign an investment agreement Tuesday at Konkuk University's KU Institute of Technology Convergence. [Enex]
Enex CEO Park Jin-gyu (front row, left) and Dermatobio CEO Ahn Seong-gwan sign an investment agreement Tuesday at Konkuk University's KU Institute of Technology Convergence. [Enex]

Enex, led by CEO Park Jin-gyu, is moving to transform itself from a home interior company into a "lifestyle solutions" enterprise through a strategic stake in a cosmetics and medical device startup.

The company invested 2 billion won (about $1.29 million) in Dermatobio, led by CEO Ahn Seong-gwan, acquiring 34,270 shares — a 6.67% stake — through a third-party allotment rights offering.

Enex said the move is not a simple entry into a new business or a financial investment, but the starting point of its "Enex 3.0" strategy — a medium-to-long-term growth plan to transform the company's existing construction-focused business structure into a future "lifestyle solutions platform."

To drive execution, Enex will launch an "Enex 3.0 Steering Committee" to oversee future business strategy, new business model development and global operations. Park and Ahn will serve as co-chairs.

Founded in 2022, Dermatobio is developing and preparing to distribute wellness, beauty and medical device products. Ahn holds a doctorate from Oxford University, completed a postdoctoral fellowship at Harvard Medical School and previously served as a professor of cosmetic science at Konkuk University.

The two companies plan to pursue four joint initiatives: a beauty and medical space infrastructure project, a living package for single-person households, an independent-living solution for the elderly, and a new commerce business on the Enex Mall platform. Cosmetics and medical device retail distribution are also under consideration.

Representatives from Chinese medical aesthetics and lifestyle companies attended the signing ceremony at Dermatobio's invitation. They included Li Xuanzhen (Korean name: Lee Hyeon-jin), director of education and marketing for medical aesthetics at China's Imei Group, and Piao Chengxi (Korean name: Park Seong-hui), director of international marketing at Evercare Medical Technology Group. Both will also participate in the Enex 3.0 Steering Committee. The companies plan to export the K-lifestyle-based solutions model to China and other Asian markets.

Enex views the investment as the starting point for a structural overhaul and the securing of future growth engines. The company plans to expand its existing kitchen, storage and living-space capabilities into solutions businesses targeting single-person households, the elderly and the aging-in-place market.

"We want to go beyond being a furniture company and transform into a lifestyle solutions platform that responds to shifting demographics and consumer environments," Park said.


freiheit@heraldcorp.com
This content was produced with the assistance of AI translation services.

MOST READ